Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Epilepsy Res ; 167: 106453, 2020 11.
Artigo em Inglês | MEDLINE | ID: mdl-32927329

RESUMO

In the wake of the pandemic COVID-19 and nationwide lockdowns gripping many countries globally, the national healthcare systems are either overwhelmed or preparing to combat this pandemic. Despite all the containment measures in place, experts opine that this novel coronavirus is here to stay as a pandemic or an endemic. Hence, it is apt to be prepared for the confrontation and its aftermath. From protecting the vulnerable individuals to providing quality care for all health conditions and maintaining essential drug supplies, it is going to be a grueling voyage. Preparedness to sustain optimal care for each health condition is a must. With a higher risk for severe COVID-19 disease in infants, need of high-dose hormonal therapy with a concern of consequent severe disease, presence of comorbidities, and a need for frequent investigations and follow-up; children with West syndrome constitute a distinctive group with special concerns. In this viewpoint, we discuss the important issues and concerns related to the management of West syndrome during COVID-19 pandemic in the South Asian context and provide potential solutions to these concerns based on the current evidence, adeptness, and consensus. Some plausible solutions include the continuation of containment and mitigation measures for COVID-19, therapeutic decision- making for West syndrome based on risk stratification, and tele-epileptology.


Assuntos
Corticosteroides/uso terapêutico , Hormônio Adrenocorticotrópico/uso terapêutico , Anticonvulsivantes/uso terapêutico , Infecções por Coronavirus/tratamento farmacológico , Pneumonia Viral/tratamento farmacológico , Espasmos Infantis/tratamento farmacológico , Telemedicina , Vigabatrina/uso terapêutico , Corticosteroides/provisão & distribuição , Hormônio Adrenocorticotrópico/provisão & distribuição , Anticonvulsivantes/provisão & distribuição , Antivirais/administração & dosagem , Betacoronavirus , COVID-19 , Tomada de Decisão Clínica , Atenção à Saúde , Interações Medicamentosas , Humanos , Lactente , Pandemias , SARS-CoV-2 , Tempo para o Tratamento , Vigabatrina/provisão & distribuição
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA